44 results on '"Pan, Catherine"'
Search Results
2. Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
3. Proteomic Analysis of Saliva from Patients with Oral Chronic Graft-Versus-Host Disease
4. Blood extracellular vesicles carrying synaptic function‐ and brain‐related proteins as potential biomarkers for Alzheimer's disease.
5. Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism
6. Functional plasticity of the BNIP-2 and Cdc42GAP Homology (BCH) domain in cell signaling and cell dynamics
7. Liquid chromatography with tandem mass spectrometry-based proteomic discovery in aging and Alzheimer’s disease
8. Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog
9. Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery
10. Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans
11. Salivary α-synuclein and DJ-1: potential biomarkers for Parkinsonʼs disease
12. DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
13. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid
14. Proteomics of Human Neurodegenerative Diseases
15. Mortalin: A Protein Associated With Progression of Parkinson Disease?
16. Proteomic Identification of Novel Proteins in Cortical Lewy Bodies
17. Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells
18. An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression.
19. Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Aβ42 and Tau.
20. BNIP-H Recruits the Cholinergic Machinery to Neurite Terminals to Promote Acetylcholine Signaling and Neuritogenesis.
21. Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ42 using Meso Scale Discovery Assays for Alzheimer's Disease.
22. YAP/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth.
23. Modularity and functional plasticity of scaffold proteins as p(l)acemakers in cell signaling
24. Phosphorylated α-Synuclein in Parkinson's Disease.
25. Salivary Tau Species are Potential Biomarkers of Alzheimer's Disease.
26. Simulating EGFR-ERK Signaling Control by Scaffold Proteins KSR and MP1 Reveals Differential Ligand-Sensitivity Co-Regulated by Cbl-CIN85 and Endophilin.
27. DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease.
28. Glycoproteomics in neurodegenerative diseases.
29. Identification of proteins in human substantia nigra.
30. Application of Targeted Quantitative Proteomics Analysis in Human Cerebrospinal Fluid Using a Liquid Chromatography Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Tandem Mass Spectrometer (LC MALDI TOF/TOF) Platform.
31. Mortalin.
32. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.
33. Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.
34. Effects of insulin deficiency or excess on hepatic gluconeogenic flux during glycogenolytic inhibition in the conscious dog.
35. Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein-Containing Extracellular Vesicles.
36. Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein.
37. Topography induces differential sensitivity on cancer cell proliferation via Rho-ROCK-Myosin contractility.
38. Cyclic stretching of soft substrates induces spreading and growth.
39. O3-01-03: Multiplex quantitative proteomics of human cerebral spinal fluid from patients with neurodegenerative diseases.
40. Characterization of Proteome of Human Cerebrospinal Fluid.
41. QUANTITATIVE PROTEOMIC ANALYSIS OF OLIGODENDROGLIOMAS WITH AND WITHOUT 1P/19Q DELETION.
42. Spatial arrangement of LD motif-interacting residues on focal adhesion targeting domain of Focal Adhesion Kinase determine domain-motif interaction affinity and specificity.
43. Epidermal Growth Factor Activates the Rho GTPase-activating Protein (GAP) Deleted in Liver Cancer 1 via Focal Adhesion Kinase and Protein Phosphatase 2A.
44. Analysis of α-Synuclein-associated Proteins by Quantitative Proteomics.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.